Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Financial Officer

President and CEO

General Counsel & Corp. Sec'y

Chief Human Resource Officer

Chief Medical Officer

Chief Business Officer

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avÃƒÅ¸6 and avÃƒÅ¸1 integrins, which is in three Phase IIa trials for idiopathic pulmonary fibrosis and primary sclerosing cholangitis. It also develops PLN-1474, a small-molecule selective inhibitor of avÃƒÅ¸1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avÃƒÅ¸8 and avÃƒÅ¸1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the tre...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-01-23	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-01-23	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-01-23	Premium	acquired	Premium	Premium	Premium	General Counsel & Corp. Sec'y
2024-01-23	Premium	acquired	Premium	Premium	Premium	Chief Human Resource Officer
2024-01-23	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-01-23	Premium	acquired	Premium	Premium	Premium	Chief Business Officer
2024-01-17	Premium	sold	Premium	Premium	Premium	Chief Business Officer
2024-01-17	Premium	sold	Premium	Premium	Premium	General Counsel & Corp. Sec'y
2024-01-17	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2024-01-17	Premium	sold	Premium	Premium	Premium	President and CEO
2024-01-17	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2023-08-04	Premium	acquired	Premium	Premium	Premium	Chief Business Officer
2023-08-04	Premium	sold	Premium	Premium	Premium	Chief Business Officer
2023-08-03	Premium	sold	Premium	Premium	Premium	Chief Business Officer
2023-08-03	Premium	acquired	Premium	Premium	Premium	Chief Business Officer
2023-07-20	Premium	sold	Premium	Premium	Premium	General Counsel & Corp. Sec'y
2023-07-17	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-07-17	Premium	sold	Premium	Premium	Premium	General Counsel & Corp. Sec'y
2023-07-17	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2023-07-17	Premium	sold	Premium	Premium	Premium	Chief Business Officer
2023-07-17	Premium	sold	Premium	Premium	Premium	President and CEO
2023-07-14	Premium	acquired	Premium	Premium	Premium	General Counsel & Corp. Sec'y
2023-07-14	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-07-14	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-07-14	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer

PLRX - Pliant Therapeutics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for PLRX